Back to EZorb Newsletter Index

 

EZorb

  

EZORB MONTHLY NEWSLETTER NOV 28, 2013

In this issue:

 

1. Share Success: Letters From Readers
2. Research News: BP Treatment Cautioned in Chronic Kidney Disease
3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb and Marvlix?
  

1. Share Success: Letters From Readers 

***************************************************

Letter I: From Alfredo K.

Received at Testimonial Submit Form on Thursday, October 17, 2013 at 13:44:29

(Unedited)

 

Hi, my name is Alfredo K., my wife was recently diagnosed with Osteoporosis and were suddenly faced with the ugly reality. More dreadful was that her doctor's prognosis and treatments which were taking drugs like Fosamax, Actonel or Evista, all notorious for countless side effects.

These drugs are designed to increase bone density by retaining dead bone mass, by killing osteoclasts, the cells that are responsible for bone resorption. In those treated with these drugs, the limited space within the bones is taken up by dead or nearly dead bone cells, which prevents new cells from being created. As a result, bones become more fragile and more vulnerable to fracture.

We've been taking EZorb for 8 months and the results are nothing short of miraculous! My wife has regain her energy and full mobility with little or no pain now. My joints and knees are no longer hurting and my low back pain is gone!

For us EZorb powder was the best alternative hands down. We chose Ezorb powder instead of capsules because the capsules are made of gelatin, a slaughterhouse bi-product and not easily metabolized by the body. EZorb powder is suitable for vegans and non vegans as it contains no animal products.

I have suggested to the makers of EZorb to replace their gelatin capsules with plant based capsules, hopefully they will change it. Thank you Elixir Industry for making EZorb, a fantastic and revolutionary product!


Letter II: From Edna

Received at Testimonial Submit Form on Tuesday, August 20, 2013 at 19:18:14

(Unedited)

 

Hi, my name is Edna. I was in a lot of pain in my hip, knee and groin; my bones rubbed together. In Florida I was told that I had hip dysplasia and I needed surgery on the hip. I came to Canada and went to an orthopedist who told me I had osteoarthritis. I was told to live with it!!

But I went on the computer and found ezorb. There are several ads for people who advertise cures, I found ezorb; it made sense. I decided to try it.

At the beginning of the second week, I found the pain at night was not as painful and I cold sleep better. Now, I am finding if I don't rush, I can walk slowly without pain and can do so without a walker. The leg feels a little stiff, and this is only the second week, can hardly believe it.

I am writing this so that people who are suffering can know that ezorb works. It works on my hands too.


Letter III: From M.D.

  

Received at Testimonial Submit Form on May 28, 2013 at 4:14 PM

(Unedited)

 

I have been taking E-zorb for almost a year and I only feel pain when I first get up in the morning and it goes away after about 15 or 20 minutes.

I had been suffering from lower back pain since I had a compression fracture of my back at 25 yrs of age. I am now 88 and doing good in that department.

Thank you for Ezorb. Nothing else had helped before.

M.D.

***************************************************

From the Desk of EZorb Newsletter Editor:

 
This newsletter is now read by over 70,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's quality of life. Your continuous support will be greatly appreciated by tens of thousands who have been suffering and would continuously suffer, without your help! Please email your story to sharesuccess @ elixirindustry.com or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public.


2. Research News: BP Treatment Cautioned in Chronic Kidney

 

Physicians should keep a close eye on diastolic blood pressure (DBP) when attempting to reduce systolic blood pressure (SBP) in patients who have chronic kidney disease (CKD), research suggests.

In a large observational study looking at all possible combinations of SBP and DBP, mortality fell with decreasing SBP only if DBP did not fall below 70 mmHg.

With this in mind, lead researcher Csaba Kovesdy (Memphis Veterans Affairs Medical Center, Tennessee, USA) and colleagues say that "an especially problematic BP pattern is where elevated SBP combines with low DBP."

This is common in CKD patients, they note, and occurred in almost a third of the 651,749 US veterans in their study at some point during follow-up between 2005 and 2012.

"A particularly vexing practical issue is to determine whether lowering the BP in such persons is beneficial by achieving SBP associated with a lower mortality rate or whether it is detrimental by concomitantly inducing an even lower DBP that is associated with higher mortality rates," says the team.

The patients were aged an average of 73.8 years at baseline, and about a third died during follow-up. SBP and DBP both had a U-shaped association with mortality, with the lowest death rates seen at an SBP range of about 140–160 mmHg and a DBP range of 80–90 mmHg.

Among guideline-defined BP categories, stage 1 hypertension was associated with the lowest mortality risk – a significant 5% lower than that associated with prehypertension (high-normal blood pressure) after accounting for multiple confounders.

By contrast, normotensive patients had the highest mortality risk, increased by 42% above that of those with prehypertension, due to the large proportion of normotensive patients with DBP below 70 mmHg. Stage 2 hypertension conferred a significant 5% increase in mortality risk.

Writing in the Annals of Internal Medicine, the researchers say that randomized trials are necessary, given the limitations of observational studies such as theirs. In the meantime, they advise caution when treating CKD patients with hypertension.

Original research was published in Ann Intern Med 2013; 159: 233–242.


3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now

  

 

4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to test @ elixirindustry.com for a copy of the instructions.

 

 

5. What Are Others Saying About EZorb and Marvlix?

EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix.

Back to EZorb Newsletter Index

 
 
 
  Copyright 2013 Elixir Industry